Notice ID: b4a84d28aaab4be1871f612f736bc568Solicitation
Whole Genome DNA Methylation and Genotyping for SL
Archived on August 22, 2024. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 7:30 AM UTC−04:00
- Posted
- July 31, 2024
- Notice type
- Solicitation
- NAICS
- 611310: Colleges, Universities, and Professional Schools
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH NHLBI
- Last updated
- Sep 9, 2025
Identifiers
- Solicitation number
- 75N92024Q1066
- Notice ID
- b4a84d28aaab4be1871f612f736bc568
Description
Whole Genome DNA Methylation and Genotyping for SLE patients Third Phase
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
75N92024Q1066- Solicitation
Award typically follows within 30–90 days after the response deadline. (estimate)
- SolicitationCurrentJul 31, 2024
Whole Genome DNA Methylation and Genotyping for SL
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98026Q01209/PCA-NIA-08501. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition (including brand-name, if applicable). This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii). The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm fix-price award on a non-competitive basis to Epigenetic Clock Development Foundation 1124 W. Carson Street, MRL Bldg., 3rd Floor Torrance, CA 90502 US to provide obtain DNA methylation profiling and epigenetic age analysis for 320 previously extracted murine DNA samples using the Mammal320K methylation array and established Horvath epigenetic clock methodologies. | 39% | Combined Synopsis | 09/23/2026 |
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98026Q01212/PCA-NIA-08124. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition (including brand-name, if applicable). This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii). The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm fix-price award on a non-competitive basis to Metabolon Inc. 617 Davis Drive, Suite 100, Morrisville, NC 27560 to assay global metabolomics data and short chain fatty acids (SCFA) via the Metabolon platform from 369 blood samples in the BLSA. These metabolomics data will be used to identify metabolomic signatures of anthropometric aging quantified via a 3D body scanner. | 39% | Combined Synopsis | 09/23/2026 |
Whole Genome DNA Methylation and Genotyping for SLE patients, Third Phase | 100% | Awarded | Open |
Whole Genome DNA EPIC Methylation Profiling SLE | 100% | Awarded | Open |
DNA Methylation Profiling and Data Collection | 76% | Awarded | Open |
Additional Details
Solicitation Number
75N92024Q1066
Archive Date
Aug 22, 2024
Office Address
BETHESDA, MD, 20892